ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.62 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹1.96 Cr |
| Mar2022 | ₹1.63 Cr |
| Mar2021 | ₹4.03 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.62 Cr | 2.17 | |
| Mar2024 | ₹4.52 Cr | 130.38 | |
| Mar2023 | ₹1.96 Cr | 20.22 | |
| Mar2022 | ₹1.63 Cr | -59.46 | |
| Mar2021 | ₹4.03 Cr | - | |
Compare Contingent Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹415.3 Cr | -3.5% | 6.4% | -31.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -3.5% |
6.4% |
-31.6% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses